Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
General	O
Medicine	O

Sample	O
Name	O
:	O
Discharge	O
Summary	O
-	O
2	O

Description	O
:	O
Patient	O
with	O
complaints	O
of	O
shortness	B-problem
of	I-problem
breath	B-bodyloc
and	O
was	O
found	O
to	O
have	O
acute	B-severity
COPD	I-problem
exacerbation	I-problem
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

ADMISSION	O
DIAGNOSIS	O
(	O
ES	O
)	O
:	O

1	O
.	O

Chronic	B-problem
obstructive	I-problem
pulmonary	B-bodyloc
disease	I-problem
.	O

2	O
.	O

Pneumonia	B-problem
.	O

3	O
.	O

Congestive	B-problem
heart	B-bodyloc
failure	I-problem
.	O

4	O
.	O

Diabetes	B-problem
mellitus	I-problem
.	O

5	O
.	O

Neuropathy	B-problem
.	O

6	O
.	O

Anxiety	B-problem
.	O

7	O
.	O

Hypothyroidism	B-problem
.	O

8	O
.	O

Depression	B-problem
.	O

9	O
.	O

Hypertension	B-problem
.	O

DISCHARGE	O
DIAGNOSIS	O
(	O
ES	O
)	O
:	O

1	O
.	O

Severe	B-severity
chronic	I-problem
obstructive	I-problem
pulmonary	B-bodyloc
disease	I-problem
.	O

2	O
.	O

Diabetes	B-problem
mellitus	I-problem
.	O

3	O
.	O

Hypothyroidism	B-problem
.	O

4	O
.	O

Altered	B-problem
mental	I-problem
status	I-problem
,	O
less	B-problem
somnolent	I-problem
,	O
likely	O
secondary	O
to	O
medications	B-treatment
,	O
resolved	O
.	O

5	O
.	O

Lower	B-bodyloc
gastrointestinal	I-bodyloc
bleed	I-problem
.	O

6	O
.	O

Status	O
post	O
episode	O
of	O
atrial	B-bodyloc
fibrillation	I-problem
.	O

7	O
.	O

Status	O
post	O
diverticular	B-problem
bleed	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1	O
.	O

Albuterol	B-drug
inhaler	B-form
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

2	O
.	O

Xanax	B-drug
1	B-strength
mg	I-strength
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

3	O
.	O

Cardizem	B-drug
CD	I-drug
120	B-strength
mg	I-strength
daily	B-frequency
.	O

4	O
.	O

Colace	B-drug
100	B-strength
mg	I-strength
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

5	O
.	O

Iron	B-drug
sulfate	I-drug
325	B-strength
mg	I-strength
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

6	O
.	O

NPH	B-drug
10	B-dosage
units	I-dosage
subcutaneous	B-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

7	O
.	O

Atrovent	B-drug
inhaler	B-form
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

8	O
.	O

Statin	B-drug
oral	B-route
suspension	B-form
p	B-route
.	I-route
o	I-route
.	O
q	B-temporal
.	I-temporal
i	I-temporal
.	I-temporal
d	I-temporal
.	I-temporal
,	O
swish	O
and	O
spit	O
.	O

9	O
.	O

Paxil	B-drug
10	B-strength
mg	I-strength
daily	B-frequency
.	O

10	O
.	O

Prednisone	B-drug
20	B-strength
mg	I-strength
daily	B-frequency
.	O

11	O
.	O

Darvocet	B-drug
Darvocet	I-drug
-	I-drug
N	I-drug
100	B-strength
,	O
one	O
q	B-frequency
.	I-frequency
4h	I-frequency
PRN	B-condition
pain	B-problem
.	O

12	O
.	O

Metamucil	B-drug
one	B-dosage
pack	B-form
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

13	O
.	O

Synthroid	B-drug
50	B-strength
mcg	I-strength
daily	B-frequency
.	O

14	O
.	O

Nexium	B-drug
40	B-strength
mg	I-strength
daily	B-frequency
.	O

HOSPITAL	O
COURSE	O
:	O
The	O
patient	O
was	O
a	O
66	O
-	O
year	O
-	O
old	O
who	O
presented	O
with	O
complaints	O
of	O
shortness	B-problem
of	I-problem
breath	B-bodyloc
and	O
was	O
found	O
to	O
have	O
acute	B-severity
COPD	I-problem
exacerbation	I-problem
.	O

She	O
had	O
previously	O
been	O
at	O
outlying	O
hospital	O
and	O
had	O
left	O
AMA	O
after	O
10	O
sets	O
of	O
BiPAP	B-treatment
use	O
.	O

Here	O
she	O
was	O
able	O
to	O
be	O
kept	O
off	O
BiPAP	B-treatment
later	O
and	O
slowly	O
improved	O
her	O
exacerbation	O
of	O
COPD	B-problem
with	O
the	O
assistance	O
of	O
pulmonary	O
.	O

She	O
was	O
thought	B-uncertain
to	I-uncertain
have	I-uncertain
bronchitis	B-problem
as	O
well	O
and	O
was	O
treated	O
with	O
antibiotics	B-drug
.	O

During	O
hospitalization	O
she	O
developed	O
acute	B-severity
lower	B-bodyloc
GI	I-bodyloc
bleed	I-problem
and	O
was	O
transferred	O
to	O
intensive	O
care	O
unit	O
and	O
transfused	O
packed	B-drug
red	I-drug
blood	I-drug
cells	I-drug
.	O

GI	O
was	O
consulted	O
,	O
performed	O
endoscopy	B-test
,	O
revealing	O
diverticular	B-problem
disease	I-problem
of	I-problem
the	I-problem
sigmoid	B-bodyloc
colon	I-bodyloc
,	O
with	O
this	O
being	O
the	O
suspected	B-uncertain
cause	I-uncertain
of	I-uncertain
hemorrhage	B-problem
.	O

Plavix	B-drug
is	O
being	O
held	O
for	O
at	O
least	O
10	B-temporal
days	I-temporal
.	O

Lovenox	B-drug
held	O
as	O
well	O
.	O

No	B-negation
further	I-negation
signs	I-negation
of	I-negation
bleeding	B-problem
.	O

The	O
patient	O
'	O
s	O
respiratory	O
status	O
did	O
slowly	O
improve	O
to	O
baseline	O
.	O

She	O
is	O
discharged	O
and	O
given	O
the	B-treatment
above	I-treatment
noted	I-treatment
medications	I-treatment
.	O

Followup	O
with	O
Dr	O
.	O
Pesce	O
,	O
of	O
diagnostic	O
pulmonary	O
,	O
in	O
the	O
outpatient	O
setting	O
.	O

She	O
will	O
also	O
followup	O
with	O
Dr	O
.	O
Pesce	O
,	O
in	O
the	O
outpatient	O
setting	O
.	O

Keywords	O
:	O

general	O
medicine	O
,	O
chronic	B-problem
obstructive	I-problem
pulmonary	B-bodyloc
disease	I-problem
,	O
pneumonia	B-problem
,	O
congestive	B-problem
heart	B-bodyloc
failure	I-problem
,	O
diabetes	B-problem
mellitus	I-problem
,	O
neuropathy	B-problem
,	O
anxiety	B-problem
,	O
hypothyroidism	B-problem
,	O
depression	B-problem
,	O
hypertension	B-problem
,	O
shortness	B-problem
of	I-problem
breath	B-bodyloc
,	O
obstructive	B-problem
pulmonary	B-bodyloc
disease	I-problem
,	O
pulmonary	B-bodyloc
disease	I-problem
,	O
discharge	B-problem
,	O
inhaler	B-treatment
,	O
copd	B-problem
,	O
exacerbation	B-problem
,	O
pulmonary	O
,	O
breath	O
,	O

